RecruitingNCT03479580

Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry


Sponsor

University Hospital, Grenoble

Enrollment

1,600 participants

Start Date

Feb 8, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Long-term prognostic value of macrovascular and microvascular coronary artery stenoses in each type of cardiomyopathy.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria4

  • Ischemic
  • Dilated
  • Hypertrophic
  • Restrictive cardiomyopathy.

Exclusion Criteria3

  • Pregnant women
  • Breastfeeding women
  • Patients under legal protection

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPatients with a cardiomyopathy

Prognostic value of coronary artery disease and microvascular disease in the different types of cardiomyopathies.


Locations(1)

University Hospital Grenoble

La Tronche, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03479580


Related Trials